Potential risk factors for Varicella-zoster virus reactivation after COVID-19 vaccination.

May Lee, Marco; Macchi, Stefano; Mora, Edoardo; Feliciani, Claudio

May Lee, Marco; Macchi, Stefano; Mora, Edoardo; Feliciani, Claudio.

May Lee M; Section of Dermatology, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
Macchi S; Section of Dermatology, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
Mora E; Section of Dermatology, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
Feliciani C; Section of Dermatology, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.

J Cosmet Dermatol ; 21(4): 1347-1349, 2022 04.

Article in English | MEDLINE | ID: covidwho-1704452

Subject(s)

COVID-19; Herpesvirus 3, Human; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Humans; Risk Factors; Vaccination/adverse effects

Keywords

COVID-19 vaccine; Varicella-zoster virus; herpes zoster reactivation

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Herpesvirus 3, Human / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: J Cosmet Dermatol Journal subject: Dermatology Year: 2022 Document Type: Article Affiliation country: Jocd.14871

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google